Welcome to our dedicated page for Predictmedix news (Ticker: PMEDF), a resource for investors and traders seeking the latest updates and insights on Predictmedix stock.
Predictmedix AI Inc. (PMEDF) is a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI). The company recently announced a partnership with KGK Science, a renowned name in clinical research, to advance health research and product development. This collaboration aims to introduce transformative changes in healthcare innovation, particularly in clinical trial efficiency and health product development. By leveraging Predictmedix AI's cutting-edge technologies and KGK Science's expertise, the partnership is set to redefine health assessment methodologies and outcomes.
KGK Science, with over 22 years of experience, is known for its expertise in clinical research and regulatory support for nutraceutical, cannabis, and hemp industries. On the other hand, Predictmedix AI's Safe Entry Stations utilize multispectral cameras to predict a variety of health issues, including vital parameters, drug impairment, fatigue, and mental illnesses. Together, these companies are focused on enhancing health research and product development through innovative technologies and creating impactful advancements in healthcare solutions.
Rhea-AI Summary
Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) proudly announces the results of a clinical validation conducted in collaboration with the University of Raharja in Indonesia. The study focused on developing AI-based software to capture vital signs like heart rate, respiration rate, body temperature, and blood pressure. The rigorous testing phase involved scanning approximately 6,000 subjects, resulting in a remarkable 95% accuracy across critical parameters. Predictmedix AI emphasizes data security, ensuring the system does not capture recognizable facial images. The Company will be issuing 350,000 common shares and 150,000 warrants as consideration for services provided by a consultant.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
News
Rhea-AI Summary
Predictmedix AI Inc. introduces its Safe Entry Stations at the D-30 event in New Delhi, India. These stations utilize advanced AI to provide non-invasive health assessments and impairment detection. The technology was showcased in various environments, including a government training institute.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Predictmedix AI has achieved significant milestones in corporate development during its overseas venture. The company has formed strategic alliances, established government collaborations, enhanced healthcare engagement, explored diversified opportunities, and made key talent acquisitions. They are actively pursuing certifications for healthcare solutions. Predictmedix AI has also established a corporate address in San Francisco, USA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.71%
Tags
Rhea-AI Summary
Predictmedix AI executives have been granted visas for a strategic visit to India to engage with institutional partners and government officials. The company aims to ensure seamless integration and scalable deployment of their contactless AI solutions, highlighting their commitment to revolutionizing healthcare and enhancing industry sectors through AI. The visit holds immense importance as it paves the way for collaboration and positive impact on healthcare and other sectors in India.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.48%
Tags
-
Rhea-AI Summary
Predictmedix AI featured in Toronto Star, highlighting their commitment to cutting-edge technology in healthcare. They have developed a Safe Entry system with 97% accuracy in contactless SPO2 measurement. This innovation has potential to revolutionize patient care and respiratory medicine in India.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.32%
Tags
-
Rhea-AI Summary
Predictmedix AI achieves significant advancements in 2023, revolutionizing healthcare through cutting-edge technology, technology validations, and strategic commercialization efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
News
Rhea-AI Summary
Predictmedix AI announces the ability to detect early signs of diabetes through AI analysis, targeting India's rising diabetes concerns.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.72%
Tags
-
Rhea-AI Summary
Predictmedix AI Inc. (CSE:PMED) (OTCQB:PMEDF) (FRA:3QP) has completed over 200,000 individual scans through its AI-powered Safe Entry Stations, marking a significant milestone. The technology plays a vital role in providing seamless and secure entry to public and private establishments, as well as in triage functionality within hospital settings. The data collected from the scans has significantly advanced the company's machine learning capabilities, allowing for more precise and reliable solutions in the healthcare industry. Predictmedix AI is prepared for a commercial rollout of Safe Entry, particularly in global markets like Indonesia and India, with a strong emphasis on privacy and explicit consent for data collection.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.48%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.95%
Tags
FAQ
What is the current stock price of Predictmedix (PMEDF)?
The current stock price of Predictmedix (PMEDF) is $0.0253 as of February 21, 2025.
What is the market cap of Predictmedix (PMEDF)?
The market cap of Predictmedix (PMEDF) is approximately 1.8M.
What is Predictmedix AI Inc. known for?
Predictmedix AI Inc. is a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI).
Who is KGK Science and what expertise do they bring to the partnership?
KGK Science is a respected name in clinical research and regulatory consulting, offering top-tier expertise in nutraceutical, cannabis, and hemp industries.
What are the key focus areas of the partnership between Predictmedix AI Inc. and KGK Science?
The partnership aims to introduce transformative changes in healthcare innovation, particularly in clinical trial efficiency and health product development.
How do Predictmedix AI's Safe Entry Stations contribute to the partnership?
Predictmedix AI's Safe Entry Stations utilize multispectral cameras to predict various health issues, including vital parameters, drug impairment, fatigue, and mental illnesses, enhancing health research and product development.
What are the expected outcomes of the collaboration between Predictmedix AI Inc. and KGK Science?
The collaboration is set to redefine health assessment methodologies and outcomes, offering impactful advancements in healthcare solutions.
Predictmedix